Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ASPIRIN Cause Intentional product use issue? 465 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 465 reports of Intentional product use issue have been filed in association with ASPIRIN (Aspirin). This represents 0.5% of all adverse event reports for ASPIRIN.

465
Reports of Intentional product use issue with ASPIRIN
0.5%
of all ASPIRIN reports
50
Deaths
168
Hospitalizations

How Dangerous Is Intentional product use issue From ASPIRIN?

Of the 465 reports, 50 (10.8%) resulted in death, 168 (36.1%) required hospitalization, and 26 (5.6%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ASPIRIN. However, 465 reports have been filed with the FAERS database.

What Other Side Effects Does ASPIRIN Cause?

Gastrointestinal haemorrhage (13,172) Anaemia (4,568) Off label use (4,283) Dyspnoea (4,280) Drug hypersensitivity (4,072) Drug ineffective (4,061) Upper gastrointestinal haemorrhage (3,411) Epistaxis (3,214) Rectal haemorrhage (3,057) Acute kidney injury (2,976)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which ASPIRIN Alternatives Have Lower Intentional product use issue Risk?

ASPIRIN vs ASPIRIN DL-LYSINE ASPIRIN vs ASPIRIN LYSINE ASPIRIN vs ASPIRIN\BUTALBITAL\CAFFEINE ASPIRIN vs ASPIRIN\CAFFEINE ASPIRIN vs ASPIRIN\CARISOPRODOL

Related Pages

ASPIRIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue ASPIRIN Demographics